Role of a second transplantation for children with acute leukemia following posttransplantation relapse: a study by the Turkish Bone Marrow Transplantation Study Group

References

• Peters C, Schrappe M, von Stackelberg A, et al. Stem-cell transplantation in children with acute lymphoblastic leukemia: a prospective international multicenter trial comparing sibling donors with matched unrelated donors—the ALL-SCT-BFM-2003 trial. J Clin Oncol. 2015;33(11):1265–1274.
   PubMed Web of Science ®Google Scholar
• Rasche M, Zimmermann M, Kellerstrass L, et al. Successes and challenges of pediatric AML: a report on survival, salvage therapy and causes of deaths in the AML-BFM Study Group from 1987–2012. Blood. 2016;128(22):450–450.
   Web of Science ®Google Scholar
• Flower A, Cairo MS. The evolution of allogeneic stem cell transplant for children and adolescents with acute myeloid leukemia. Clin Adv Hematol Oncol. 2017;15(1):52–62.
   PubMed Web of Science ®Google Scholar
• Creutzig U, van den Heuvel-Eibrink MM, Gibson B, et al. AML Committee of the International BFM Study Group. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood. 2012;120(16):3187–3205.
   PubMed Web of Science ®Google Scholar
• Gorman MF, Ji L, Ko RH, et al. Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study. Pediatr Blood Cancer. 2010;55(3):421–429.
   PubMed Web of Science ®Google Scholar
• Abrahamsson J, Clausen N, Gustafsson G, et al. Nordic Society for Paediatric Haematology and Oncology (NOPHO). Improved outcome after relapse in children with acute myeloid leukaemia. Br J Haematol. 2007;136(2):229–236.
   PubMedGoogle Scholar
• Arellano ML, Langston A, Winton E, et al. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience. Biol Blood Marrow Transplant. 2007;13(1):116–123.
   PubMed Web of Science ®Google Scholar
• Bajwa R, Schechter T, Soni S, et al. Outcome of children who experience disease relapse following allogeneic hematopoietic SCT for hematologic malignancies. Bone Marrow Transplant. 2013;48(5):661–665.
   PubMed Web of Science ®Google Scholar
• Michallet M, Tanguy ML, Socie G, et al. Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de moelle (SFGM). Br J Haematol. 2000;108:400–407.
   PubMed Web of Science ®Google Scholar
• Porter DL, Alyea EP, Antin JH, et al. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the committee on treatment of relapse after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2010;16(11):1467–1503.
   PubMed Web of Science ®Google Scholar
• Bosi A, Laszlo D, Labopin M, et al. Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation. J Clin Oncol. 2001;19(16):3675–3684.
   PubMed Web of Science ®Google Scholar
• Kato M, Horikoshi Y, Okamoto Y, et al. Second allogeneic hematopoietic SCT for relapsed ALL in children. Bone Marrow Transplant. 2012;47(10):1307–1311.
   PubMed Web of Science ®Google Scholar
• Taga T, Murakami Y, Tabuchi K, et al. Role of second transplantation for children with acute myeloid leukemia following posttransplantation relapse. Pediatr Blood Cancer. 2016;63(4):701–705.
   PubMed Web of Science ®Google Scholar
• Yaniv I, Krauss AC, Beohou E, et al. Second hematopoietic stem cell transplantation for post-transplantation relapsed acute leukemia in children: a retrospective EBMT-PDWP study. Biol Blood Marrow Transplant. 2018;24(8):1629–1642.
   PubMed Web of Science ®Google Scholar
• Muñoz A, Badell I, Olivé T, et al. Second allogeneic hematopoietic stem cell transplantation in hematologic malignancies in children: long-term results of a multicenter study of the Spanish Working Party for Bone Marrow Transplantation in Children (GETMON). Bone Marrow Transplant. 2002;87:331–332.
   Google Scholar
• Meshinchi S, Leisenring WM, Carpenter PA, et al. Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia. Biol Blood Marrow Transplant. 2003;9(11):706–713.
   PubMed Web of Science ®Google Scholar
• Oda M, Isoyama K, Ito E, et al. Survival after cord blood transplantation from unrelated donor as a second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia. Int J Hematol. 2009;89(3):374–382.
   PubMed Web of Science ®Google Scholar
• Chueh HW, Lee SH, Sung KW, et al. Second allogeneic stem cell transplantation in hematologic malignancies: a single-center experience. J Pediar Hematol Oncol. 2013;35(6):424–429.
   PubMed Web of Science ®Google Scholar
• Naik S, Martinez C, Leung K, et al. Outcomes after second hematopoietic stem cell transplantations in pediatric patients with relapsed hematological malignancies. Biol Blood Marrow Transplant. 2015;21(7):1266–1272.
   PubMed Web of Science ®Google Scholar
• Mennon NN, Jenkins LM, Cui H, et al. Factors associated with improved outcomes after second allogeneic hematopoietic cell transplantation for relapsed pediatric leukemia. Ann Hematol. 2016;95:637–644.
   PubMed Web of Science ®Google Scholar
• Stafford L, Troy JD, Driscoll TA, et al. Outcomes of second transplants for patients with hematological malignancies who relapse after first transplant: a retrospective analysis of a single institution experience. Biol Blood Marrow Transplant. 2017;23(3):S177.
   Google Scholar
• Duncan CN, Majhail NS, Brazauskas R, et al. Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes. Biol Blood Marrow Transplant. 2015;21(1):151–158.
   PubMed Web of Science ®Google Scholar
• Eapen M, Giralt SA, Horowitz MM, et al. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplant. 2004;34(8):721–727.
   PubMed Web of Science ®Google Scholar
• Shaw BE, Mufti GJ, Mackinnon S, et al. Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant. Bone Marrow Transplant. 2008;42(12):783–789.
   PubMed Web of Science ®Google Scholar
• Mrsíc M, Horowitz MM, Atkinson K, et al. Second HLA-identical sibling transplants for leukemia recurrence. Bone Marrow Transplant. 1992;9(4):269–275.
   PubMed Web of Science ®Google Scholar
• Al-Qurashi F, Ayas M, Al Sharif F, et al. Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution. Hematology. 2004;9:123–129.
   PubMedGoogle Scholar